Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
LVWR vs IMNN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
LVWR Captures Overall Composite Edge (51.6 HOLD vs 44.7 HOLD), While IMNN Leads 3–2 on Growth & Valuation Pillars
LVWR Overall Winner
6-Pillar Tally: LVWR 2 – 3 IMNN (1 Tie)
Matrix Metrics: LVWR 5 – 5 IMNN
As of Nov 20, 2026, LiveWire Group, Inc. (LVWR) captures the overall head-to-head institutional edge over Imunon, Inc. (IMNN) on higher Unified Composite conviction (51.6/100 HOLD vs. 44.7/100 HOLD) after splitting the core matrix 5–5 (led by Growth & Scale, Options & Positioning), while IMNN wins 3–2 across the 6-pillar growth and valuation breakdown. LVWR trades at $0.99 (N/M Forward P/E, -212.0% operating margin) versus IMNN at $0.54 (16.8x Forward P/E, 0.0% operating margin).
- Growth vs. Quality Trade-Off: LVWR earns the overall head-to-head edge with a stronger Unified Composite Score (51.6/100 HOLD vs. IMNN 44.7/100 HOLD) and -1.22β · 405% Vol risk profile, whereas IMNN leads top-line expansion (+0.0% YoY revenue growth, 5.03x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
- Technical & Structure Timing Caution: LVWR is currently in a Breakdown options structure phase (RSI 55.7); meanwhile IMNN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About LVWR vs IMNN
LVWR
Head-to-Head Winner
LiveWire Group, Inc.
$0.99
+51.63% 1D
Market Cap
$134.1M
TTM Revenue
$33M
Forward P/E
N/M
Beta / 30D Vol
-1.22β · 405% Vol
Unified Composite Score
51.6
HOLD
Tech 55.0
Fund 53.0
Flow 57.0
Mom 46.0
Weinstein Technical Phase
Neutral · Hold
IMNN
Imunon, Inc. Common Stock
$0.54
-5.22% 1D
Market Cap
$3.7M
TTM Revenue
$125,000
Forward P/E
16.8x
Beta / 30D Vol
0.50β · 120% Vol
Unified Composite Score
44.7
HOLD
Tech 45.0
Fund 51.0
Flow 50.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (LVWR 2 – 3 IMNN)
1. Valuation Multiples
IMNN
Forward P/E
N/M
16.8x
Trailing P/E
N/M
16.8x
PEG Ratio
N/M
5.03x
EV / Revenue
5.1x
N/M
2. Growth & Scale
LVWR
Revenue Growth (YoY)
+37.9%
+0.0%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$33M
$125,000
Market Cap
$134.1M
$3.7M
3. Profitability & Quality
IMNN
Gross Margin
-4.0%
N/A
Operating Margin
-212.0%
0.0%
Net Profit Margin
-217.0%
0.0%
Return on Equity (ROE)
-257.9%
-429.7%
4. Balance Sheet & Cash Flow
IMNN
Cash Generation (TTM)
-$50M
-$15M EBITDA
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$38M Net Debt
$3.9M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
LVWR
Options Structure Phase
BREAKDOWN
UNCLASSIFIED
Current IV / %ile
837.3% (100th %ile)
N/A (N/A)
Put/Call OI Skew
14.32x (Put-Skewed)
N/A
OBV Trend / Tech Phase
ACCUMULATION · Neutral
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Recreational Vehicles Operator
Biotechnology Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: LVWR (5) vs IMNN (5)| Institutional Metric | LVWR | IMNN | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $134.1M | $3.7M | LVWR | |
| Trailing P/E Ratio | N/M | 16.8x | IMNN | |
| Forward P/E Ratio | N/M | 16.8x | IMNN | |
| Revenue Growth (YoY) | +37.9% | +0.0% | LVWR | |
| Operating Margin (TTM) | -212.0% | 0.0% | IMNN | |
| Net Profit Margin | -217.0% | 0.0% | IMNN | |
| Return on Equity (ROE) | -257.9% | -429.7% | LVWR | |
| 52-Week Range Position | 15% ($0–$5) | 1% ($0–$4) | LVWR | |
| Beta / 30D Volatility | -1.22β · 405% Vol | 0.50β · 120% Vol | IMNN | |
| Unified Institutional Score | 51.6 / 100 (HOLD) | 44.7 / 100 (HOLD) | LVWR | |
| Trailing 12M Revenue (USD) | $33M | $125,000 | Scale | |
| Gross Profit Margin (TTM) | -4.0% | N/A | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 5.1x EV/Rev | 5.03x PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$50M ($38M Net Debt) | -$15M EBITDA ($3.9M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
LVWR +16.8 pp
3M Horizon
LVWR +44.27 pp
6M Horizon
LVWR +46.88 pp
1Y Horizon
LVWR +11.41 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | LVWR Revenue | IMNN Revenue | LVWR Op. Margin | IMNN Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | N/A | $0M | N/A | -4213.0% | IMNN |
| FY2019 | N/A | $0M | N/A | -4113.1% | IMNN |
| FY2020 | $30M | $0M | -249.7% | -3697.3% | LVWR |
| FY2021 | $40M | $0M | -190.4% | -4201.4% | LVWR |
| FY2022 | $50M | $0M | -181.4% | -4984.3% | LVWR |
| FY2023 | $40M | N/A | -305.0% | N/A | LVWR |
| FY2024 | $30M | N/A | -414.4% | N/A | LVWR |
| FY2025 | $30M | N/A | -294.0% | N/A | LVWR |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
LVWR
BREAKDOWN
Current IV
837.3%
IV Percentile
100th %ile
Put/Call OI Skew
14.32x (Put-Skewed)
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact LVWR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
IMNN
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact IMNN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
LVWR Moat Profile
Cyclical / Execution-Driven Positioning
Recreational Vehicles Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
IMNN Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ LVWR vs IMNN Key Questions & Quantitative Answers
As of Nov 20, 2026, LiveWire Group, Inc. (LVWR) captures the overall head-to-head institutional edge over Imunon, Inc. (IMNN) on higher Unified Composite conviction (51.6/100 HOLD vs. 44.7/100 HOLD) after splitting the core matrix 5–5 (led by Growth & Scale, Options & Positioning), while IMNN wins 3–2 across the 6-pillar growth and valuation breakdown. LVWR trades at $0.99 (N/M Forward P/E, -212.0% operating margin) versus IMNN at $0.54 (16.8x Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: LVWR earns the overall head-to-head edge with a stronger Unified Composite Score (51.6/100 HOLD vs. IMNN 44.7/100 HOLD) and -1.22β · 405% Vol risk profile, whereas IMNN leads top-line expansion (+0.0% YoY revenue growth, 5.03x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: LVWR is currently in a Breakdown options structure phase (RSI 55.7); meanwhile IMNN is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 24.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LVWR leads the Growth & Scale pillar: LVWR posts +37.9% YoY revenue growth and +0.0% YoY earnings growth on $33M TTM revenue (-4.0% gross margin, -212.0% operating margin), compared with IMNN at +0.0% YoY revenue growth and +0.0% YoY earnings growth on $125,000 TTM revenue (N/A gross margin, 0.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), LVWR cumulative revenue shifted +0.0% while IMNN shifted N/A. In operating R&D and SG&A reinvestment, LVWR deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IMNN.
IMNN screens cheaper on headline valuation multiples. LVWR trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 5.1x EV/Revenue (unreported FCF margin), whereas IMNN trades at 16.8x Forward P/E, 16.8x Trailing P/E, 5.03x PEG, and N/M EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LVWR (-257.9% ROE) versus IMNN (-429.7% ROE) capital efficiency.
In options market volatility and institutional positioning, LVWR carries 837.3% implied volatility (100th %ile, Extreme (>80th %ile)), a 14.32x (Put-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (-1.22β · 405% Vol realized risk). By comparison, IMNN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.50β · 120% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
IMNN vs LVWR · Reverse Pair
LVWR vs AIIO
· Sector Peer
LVWR vs OMH
· Sector Peer
LVWR vs VEEE
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking